Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Nuo Therapeutics, Inc.

AURX · OTC · CIK 0001091596 · Healthcare · Biotechnology

INSIDER SIGNAL

35.8 / 100

1 buyers · 2 purchase transaction lines · $9.5K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeLow
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+1.5 / 25
Role+13.0 / 20
Recency+4.3 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Role scores low · most senior buyer: CEO/CFO (CEO, chair and 10% owners score lowest)

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
JORDEN DAVID EMERSONCEO/CFO
○○○○●○●
Pittman Scott M.Director,TenPercentOwner
○○
WINZER C ERICDirector
○○
● Purchase▼ Sale○ Other

—

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: JORDEN DAVID EMERSON · $9.5K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-08-27–2026-08-28

Roles in the peak window: CEO/CFO. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

35.8 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 36.2
  2. 36.1
  3. 36.0
  4. 35.9
  5. 35.8

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

2Purchases
1Sales
17Other Form 4 lines
11SEC filings · 365 days
BUYING2 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER9 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+4.0%
3M
+35.3%
6M
-23.5%
12M
-46.7%

Volatility & liquidity

Volatility
96.2%
Beta
—
Avg daily value
USD 4,000

Valuation

Market cap
USD 63.0M
P/E
—

Fundamentals

Profit margin
-75.8%
ROE
—
Industry
Biotechnology

Market data

Price data up to: 2026-10-09 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-12 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
551
Previous report
5,153
Avg daily volume
4,968
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-28JORDEN DAVID EMERSONPurchase (P)Common Stock7,984USD 1.09USD 8,703SEC filing ↗
2026-08-27JORDEN DAVID EMERSONPurchase (P)Common Stock789USD 1.07USD 844SEC filing ↗
2025-07-30SHEEDY CHARLES EPurchase (P)Common Stock133,333USD 1.50USD 200,000SEC filing ↗
2024-09-18SHEEDY CHARLES EPurchase (P)Common Stock125,000USD 0.75USD 93,750SEC filing ↗
2024-05-20SHEEDY CHARLES EPurchase (P)Common Stock100,000USD 0.75USD 75,000SEC filing ↗
2023-12-19SHEEDY CHARLES EPurchase (P)Common Stock150,000USD 0.50USD 75,000SEC filing ↗
2023-08-01SHEEDY CHARLES EPurchase (P)Common Stock62,500USD 2.00USD 125,000SEC filing ↗
2022-04-29SHEEDY CHARLES EPurchase (P)Common Stock804,868USD 1.00USD 804,868SEC filing ↗
2020-10-05SHEEDY CHARLES EPurchase (P)Common Stock175,000USD 0.40USD 70,000SEC filing ↗

Form 4 evidence

20 transaction lines in the latest 365-day window; 67 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-28JORDEN DAVID EMERSONPurchase (P)Common Stock7,984USD 1.09USD 8,703SEC filing ↗
2026-08-28JORDEN DAVID EMERSONAward / grant (A)Common Stock7,984USD 1.09USD 8,703SEC filing ↗
2026-08-27JORDEN DAVID EMERSONPurchase (P)Common Stock789USD 1.07USD 844SEC filing ↗
Show recent Form 4 evidence (20 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-28JORDEN DAVID EMERSONPurchase (P)Common Stock7,984USD 1.09USD 8,703SEC filing ↗
2026-08-28JORDEN DAVID EMERSONAward / grant (A)Common Stock7,984USD 1.09USD 8,703SEC filing ↗
2026-08-27JORDEN DAVID EMERSONPurchase (P)Common Stock789USD 1.07USD 844SEC filing ↗
2026-08-27JORDEN DAVID EMERSONAward / grant (A)Common Stock789USD 1.07USD 844SEC filing ↗
2026-06-30WINZER C ERICOption exercise / conversion (M)Common Stock40,000USD 1.00USD 40,000SEC filing ↗
2026-06-30WINZER C ERICTax withholding (F)Common Stock39,604USD 1.01USD 40,000SEC filing ↗
2026-06-30Pittman Scott M.Option exercise / conversion (M)Common Stock40,000USD 1.00USD 40,000SEC filing ↗
2026-06-30Pittman Scott M.Tax withholding (F)Common Stock39,604USD 1.01USD 40,000SEC filing ↗
2026-06-30JORDEN DAVID EMERSONOption exercise / conversion (M)Common Stock162,500USD 1.00USD 162,500SEC filing ↗
2026-06-30JORDEN DAVID EMERSONTax withholding (F)Common Stock160,892USD 1.01USD 162,501SEC filing ↗
2026-06-05JORDEN DAVID EMERSONAward / grant (A)Common Stock13,245USD 1.10USD 14,570SEC filing ↗
2026-01-01JORDEN DAVID EMERSONOption exercise / conversion (M)Common Stock125,000USD 0.40USD 50,000SEC filing ↗
2026-01-01JORDEN DAVID EMERSONTax withholding (F)Common Stock25,381USD 1.97USD 50,001SEC filing ↗
2025-12-17WINZER C ERICOption exercise / conversion (M)Common Stock68,750USD 0.40USD 27,500SEC filing ↗
2025-12-17WINZER C ERICTax withholding (F)Common Stock13,750USD 2.00USD 27,500SEC filing ↗
2025-12-09Mintz PaulOption exercise / conversion (M)Common Stock50,000USD 0.40USD 20,000SEC filing ↗
2025-12-09Mintz PaulOption exercise / conversion (M)Common Stock50,000USD 0.40USD 20,000SEC filing ↗
2025-12-09Mintz PaulTax withholding (F)Common Stock9,091USD 2.20USD 20,000SEC filing ↗
2025-12-09Mintz PaulTax withholding (F)Common Stock9,091USD 2.20USD 20,000SEC filing ↗
2025-11-28JORDEN DAVID EMERSONSale (S)Common Stock200,000USD 1.50USD 300,000SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerAURX
CIK0001091596
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeOTC

Data coverage

Local Form 4 history67 transaction lines from 2020-10-05 to 2026-08-28
9 P purchase lines · 8 S sale lines · 50 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.